Corbus Pharmaceuticals Holding
Ownership
Ownership Structure
Who owns Corbus Pharmaceuticals Holding (CRBP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.4% of the shares are freely tradable; institutional investors hold 72.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Cormorant Asset Management, LLC | 12.12 | 2,344,971 | +0.0 | 03/31/2026 |
| Orbimed Advisors LLC | 8.98 | 1,737,287 | +8.8 | 03/31/2026 |
| Aberdeen Group PLC | 6.83 | 1,321,750 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.80 | 734,106 | +0.0 | 03/31/2026 |
| Jones Hill Capital LP | 3.38 | 653,572 | +0.0 | 06/30/2026 |
| Prosight Management, LP | 3.36 | 650,000 | -6.8 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn Healthcare Investors | 4.02 | 778,031 | +0.0 | 07/31/2026 |
| abrdn Life Sciences Investors | 2.81 | 543,719 | +0.0 | 07/31/2026 |
| Biotech Growth Ord | 2.78 | 538,600 | +0.0 | 05/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.76 | 533,575 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Cohen Yuval | Chief Executive Officer | 157,316 | 1,148,407 $ | Aug 7, 2026 | direct |
| Moran Sean F. | Chief Financial Officer | 84,694 | 618,266 $ | Aug 7, 2026 | direct |
| Saxena Nishant C | Chief Business Officer | 77,900 | 568,670 $ | Aug 11, 2026 | direct |
| Nicacio Leonardo Viana | Chief Medical Officer | 58,333 | 425,831 $ | Aug 16, 2026 | direct |
| Ben Yong | Director | 9,383 | 68,496 $ | Sep 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Ben Yong | Director | Sell | 2,000 | 7.84 | 15,683 |
| Aug 16, 2026 | Nicacio Leonardo Viana | Chief Medical Officer | Other | 58,333 | 0.00 | – |
| Aug 11, 2026 | Saxena Nishant C | Chief Business Officer | Buy | 2,600 | 9.63 | 25,036 |
| Aug 7, 2026 | Cohen Yuval | Chief Executive Officer | Sell | 17,000 | 10.08 | 171,396 |
| Aug 7, 2026 | Moran Sean F. | Chief Financial Officer | Sell | 12,000 | 10.08 | 120,971 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.